LivaNova (LIVN) Competitors $51.13 -0.49 (-0.95%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LIVN vs. CNMD, HAE, INMD, NTUS, BLFS, SNN, PEN, GKOS, BLCO, and INSPShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include CONMED (CNMD), Haemonetics (HAE), InMode (INMD), Natus Medical (NTUS), BioLife Solutions (BLFS), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), and Inspire Medical Systems (INSP). These companies are all part of the "medical" sector. LivaNova vs. CONMED Haemonetics InMode Natus Medical BioLife Solutions Smith & Nephew Penumbra Glaukos Bausch + Lomb Inspire Medical Systems CONMED (NYSE:CNMD) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations, community ranking and profitability. Which has more volatility and risk, CNMD or LIVN? CONMED has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500. Do analysts recommend CNMD or LIVN? CONMED currently has a consensus target price of $79.80, suggesting a potential upside of 13.40%. LivaNova has a consensus target price of $69.17, suggesting a potential upside of 35.28%. Given LivaNova's stronger consensus rating and higher probable upside, analysts clearly believe LivaNova is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80LivaNova 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is CNMD or LIVN more profitable? CONMED has a net margin of 10.23% compared to LivaNova's net margin of 1.91%. CONMED's return on equity of 14.15% beat LivaNova's return on equity.Company Net Margins Return on Equity Return on Assets CONMED10.23% 14.15% 5.27% LivaNova 1.91%13.81%7.07% Does the media refer more to CNMD or LIVN? In the previous week, CONMED had 2 more articles in the media than LivaNova. MarketBeat recorded 17 mentions for CONMED and 15 mentions for LivaNova. CONMED's average media sentiment score of 0.72 beat LivaNova's score of 0.64 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 3 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of CNMD or LIVN? 97.6% of LivaNova shares are held by institutional investors. 6.8% of CONMED shares are held by company insiders. Comparatively, 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community prefer CNMD or LIVN? LivaNova received 354 more outperform votes than CONMED when rated by MarketBeat users. Likewise, 69.04% of users gave LivaNova an outperform vote while only 47.89% of users gave CONMED an outperform vote. CompanyUnderperformOutperformCONMEDOutperform Votes3447.89% Underperform Votes3752.11% LivaNovaOutperform Votes38869.04% Underperform Votes17430.96% Which has stronger valuation & earnings, CNMD or LIVN? CONMED has higher revenue and earnings than LivaNova. CONMED is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.29B1.68$64.46M$4.2116.71LivaNova$1.24B2.24$17.55M$0.42121.74 SummaryLivaNova beats CONMED on 10 of the 19 factors compared between the two stocks. Ad InvestorPlaceWhy Buffett, Bezos, & Congress Are Piling Into This One SectorWhy are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.80B$3.56B$5.54B$8.53BDividend YieldN/A1.61%5.13%4.14%P/E Ratio121.7416.58114.8115.14Price / Sales2.2457.091,495.55100.10Price / Cash11.9346.0939.6734.08Price / Book2.123.504.665.02Net Income$17.55M$89.83M$119.06M$225.46M7 Day Performance-3.53%0.67%0.80%0.37%1 Month Performance-4.89%13.87%5.65%3.57%1 Year Performance5.05%17.61%36.75%29.43% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova4.4844 of 5 stars$51.13-0.9%$69.17+35.3%+2.2%$2.80B$1.24B121.742,900Analyst ForecastNews CoverageCNMDCONMED4.8114 of 5 stars$70.37+3.1%$79.80+13.4%-28.7%$2.17B$1.29B16.714,000Earnings ReportAnalyst ForecastNews CoverageHAEHaemonetics4.856 of 5 stars$71.47+0.4%$106.14+48.5%-17.3%$3.66B$1.31B32.053,657Upcoming EarningsNews CoverageINMDInMode3.6277 of 5 stars$17.26+1.1%$22.60+30.9%-9.3%$1.45B$492.05M9.33480Analyst ForecastNews CoverageNTUSNatus MedicalN/A$32.96flatN/A+0.0%$1.14B$473.44M89.081,400BLFSBioLife Solutions1.3451 of 5 stars$24.07+2.9%$26.67+10.8%+135.3%$1.11B$143.27M-14.24409News CoveragePositive NewsSNNSmith & Nephew1.9164 of 5 stars$25.24+0.6%N/A+13.1%$10.97B$5.55B0.0018,452Analyst DowngradeNews CoverageGap UpPENPenumbra3.9071 of 5 stars$233.38+2.0%$226.67-2.9%+20.2%$9.06B$1.06B271.374,200Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGKOSGlaukos3.6946 of 5 stars$131.70-0.4%$130.45-0.9%+89.5%$7.24B$314.71M-40.40780Upcoming EarningsInsider SellingBLCOBausch + Lomb2.3493 of 5 stars$20.51+1.1%$20.91+1.9%+24.2%$7.22B$4.15B-19.5313,300Analyst ForecastShort Interest ↑News CoverageINSPInspire Medical Systems4.7114 of 5 stars$190.67-2.2%$219.58+15.2%+22.0%$5.82B$705.71M1,059.281,011Upcoming EarningsNews Coverage Related Companies and Tools Related Companies CNMD Alternatives HAE Alternatives INMD Alternatives NTUS Alternatives BLFS Alternatives SNN Alternatives PEN Alternatives GKOS Alternatives BLCO Alternatives INSP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIVN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
